The systemic involvement in AGEP, such as hepatitis or renal insufficiency, may be due to the circulating interleukin (IL)-17 and IL-22.[1,5] Nevertheless, the exact mechanism is uncertain. This evidence concerns the gene IL17A and Hepatitis.